510(k) Report

510(k) · Cleared

Cleared

Elecsys Syphilis

K211302510(k) TraditionalCleared Jul 20, 202182-day reviewClass II21 CFR 866.3830

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostics · LIP Enzyme Linked Immunoabsorption Assay, Treponema Pallidum

Cleared on Jul 20, 2021 as substantially equivalent to K160910 (Roche Diagnostics, 2016) after an 82-day review. Its family tree reaches back 4 generations to 2002. 1 later device descends from it.

Decided
Jul 20, 2021
Review
82 days
Class
Class II
Product code
LIP
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K014233 (2002). 1 later device descends from it, 1 citing it directly.

  1. Root · 4 generations backK014233 Captiam Syphilis-G AssayTrinity Biotech, Plc · 2002
  2. 3 generations backK061247 Diasorin Liaison Treponema AssayDiaSorin, Inc. · 2006
  3. 2 generations backK091361 Immulite 2000 Syphilis Screen Test SystemSiemens Healthcare Diagnostics · 2009 · Recalled
  4. 1 generation backK160910 Elecsys SyphilisRoche Diagnostics · 2016
  5. This deviceK211302 Elecsys SyphilisRoche Diagnostics · 2021
  6. Descendant · cites it directly · 0 of its ownK241534 VITROS Immunodiagnostic Products Syphilis Reagent PackOrtho Clinical Diagnostics · 2024

Most influential descendants

Showing 1 of 1 · See all
  • K241534VITROS Immunodiagnostic Products Syphilis Reagent PackOrtho Clinical Diagnostics · 2024 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K014233Captiam Syphilis-G AssayTrinity Biotech, Plc2002—
−3K061247Diasorin Liaison Treponema AssayDiaSorin, Inc.2006—
−2K091361Immulite 2000 Syphilis Screen Test SystemSiemens Healthcare Diagnostics20092
−1K160910Elecsys SyphilisRoche Diagnostics2016—
0 (this device)K211302Elecsys SyphilisRoche Diagnostics2021—
+1K241534VITROS Immunodiagnostic Products Syphilis Reagent PackOrtho Clinical Diagnostics2024—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202410
FIG. 1 — Lineage of K211302, 2002–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LIP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LIP device

  1. #1 K241534 VITROS Immunodiagnostic Products Syphilis…score 9.1 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K160910Elecsys Syphilis
Summary page 4
…eponema pallidum treponemal test reagent Product Codes, Product Code: LIP; 21CFR866.3830 Regulation Numbers Predicate Devices Elecsys Syphilis (K160910) Roche Diagnostics GmbH Mannheim, Germany: 9610126 Establishment Roche Diagnostics GmbH Penzberg, G…
Roche Diagnostics2016—

Also cleared against K160910: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K241534VITROS Immunodiagnostic Products Syphilis Reagent PackOrtho Clinical Diagnostics20240

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 19 years and passes through 4 companies; a new generation was cleared every 5.0 years on median.
  • 1 of the 4 ancestors has a recall of any class.
  • Of its descendants, K241534 (Ortho Clinical Diagnostics, 2024) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K160910.

How does its category compare?

All LIP devices

LIP Enzyme Linked Immunoabsorption Assay, Treponema Pallidum: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · LIP

2in 2024

2007: 12009: 12010: 12011: 22012: 22016: 32017: 12021: 12024: 2
2007high 3 (2016) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LIP

170in 2016

2016: 170 days median
2007high 170 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LIP

2in 2022

2007: 22010: 12013: 12014: 12021: 22022: 22026 (partial year): 2
2007high 2 (2007) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LIP

112in 2025

2010: 12012: 12013: 42014: 12015: 22016: 12017: 32018: 52019: 92020: 462021: 542022: 442023: 662024: 732025: 112
2007high 112 (2025) · low 0 (2007)2025

MAUDE reports naming product code LIP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—20
20080—00
20091—00
20101—11
20112—00
20122—01
20130—14
20140—11
20150—02
2016317001
20171—03
20180—05
20190—09
20200—046
20211—254
20220—244
20230—066
20242—073
20250—0112
20260—2—

What is it indicated for?

Immunoassay for the in vitro qualitative detection of total antibodies (lgG and IgM) to Treponema pallidum in human serum and plasma. The test is intended as an aid in the diagnosis of syphilis infection in conjunction with clinical signs and symptoms.

The Elecsys Syphilis immunoassay is not intended for use in screening blood or tissue donors. The effectiveness of this assay in testing blood or tissue donors has not been established.

The electrochemiluminescence immunoassay "ECLIA" is intended for use on cobas e immunoassay analyzers.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K211302: Elecsys Syphilis.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K211302

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026